[go: up one dir, main page]

WO2008037937A3 - Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme - Google Patents

Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme Download PDF

Info

Publication number
WO2008037937A3
WO2008037937A3 PCT/FR2007/052042 FR2007052042W WO2008037937A3 WO 2008037937 A3 WO2008037937 A3 WO 2008037937A3 FR 2007052042 W FR2007052042 W FR 2007052042W WO 2008037937 A3 WO2008037937 A3 WO 2008037937A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
treatment
human beings
dermatological disorders
milbemycin family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2007/052042
Other languages
English (en)
Other versions
WO2008037937A2 (fr
Inventor
Alexandre Kaoukhov
Cécile COUSIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to EP07823877A priority Critical patent/EP2124932A2/fr
Publication of WO2008037937A2 publication Critical patent/WO2008037937A2/fr
Priority to US12/382,891 priority patent/US20090264517A1/en
Anticipated expiration legal-status Critical
Publication of WO2008037937A3 publication Critical patent/WO2008037937A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention se rapporte à l'utilisation de composés de la famille des milbémycines ou leurs dérivés pour la fabrication d'une composition pharmaceutique destinée au traitement d'affections dermatologiques chez l'homme, notamment la rosacée.
PCT/FR2007/052042 2006-09-28 2007-09-27 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme Ceased WO2008037937A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP07823877A EP2124932A2 (fr) 2006-09-28 2007-09-27 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
US12/382,891 US20090264517A1 (en) 2006-09-28 2009-03-26 Milbemycin compounds and treatment of dermatological disorders in humans therewith

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0654004A FR2906467B1 (fr) 2006-09-28 2006-09-28 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
FR0654004 2006-09-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/382,891 Continuation US20090264517A1 (en) 2006-09-28 2009-03-26 Milbemycin compounds and treatment of dermatological disorders in humans therewith

Publications (2)

Publication Number Publication Date
WO2008037937A2 WO2008037937A2 (fr) 2008-04-03
WO2008037937A3 true WO2008037937A3 (fr) 2009-12-23

Family

ID=37798437

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/052042 Ceased WO2008037937A2 (fr) 2006-09-28 2007-09-27 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme

Country Status (4)

Country Link
US (1) US20090264517A1 (fr)
EP (1) EP2124932A2 (fr)
FR (1) FR2906467B1 (fr)
WO (1) WO2008037937A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2669942C1 (ru) * 2013-11-29 2018-10-17 Галдерма Са Соединение семейства авермектина или семейства мильбемицина для лечения и/или профилактики атопического дерматита
CN105085540B (zh) * 2015-08-12 2017-07-07 内蒙古佳瑞米精细化工有限公司 一种制备高含量尼莫克汀的方法
CN105418631B (zh) * 2015-12-07 2017-12-26 苏州纳微科技有限公司 一种用高效液相色谱分离纯化奈马菌素的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0329460A2 (fr) * 1988-02-18 1989-08-23 American Cyanamid Company Compositions stabilisées de macrolides
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
WO2005089806A1 (fr) * 2004-03-18 2005-09-29 Galderma S.A. Gel-creme contenant de l'invermectine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU713580B2 (en) * 1995-09-25 1999-12-02 Merial Ltd Anthelmintic macrocyclic lactone compositions
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
CA2446356C (fr) * 2001-05-09 2012-07-10 The Regents Of The University Of Michigan Compositions pour le traitement de l'acne rosacee
US6627613B2 (en) * 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
WO2006119174A1 (fr) * 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Methode de traitement oculaire de demodex
FR2907013B1 (fr) * 2006-10-12 2012-09-21 Galderma Sa Produits de soin cutane a double compartiment comprenant de l'ivermectine, et leurs utilisations

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0329460A2 (fr) * 1988-02-18 1989-08-23 American Cyanamid Company Compositions stabilisées de macrolides
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
WO2005089806A1 (fr) * 2004-03-18 2005-09-29 Galderma S.A. Gel-creme contenant de l'invermectine

Also Published As

Publication number Publication date
FR2906467A1 (fr) 2008-04-04
WO2008037937A2 (fr) 2008-04-03
FR2906467B1 (fr) 2012-11-09
US20090264517A1 (en) 2009-10-22
EP2124932A2 (fr) 2009-12-02

Similar Documents

Publication Publication Date Title
WO2007038459A3 (fr) Composes de carboxyamine et leurs methodes d'utilisation
WO2007119028A9 (fr) Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
WO2007104789A3 (fr) Dérivés d'amyline
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
WO2007093880A3 (fr) Nouveaux dérivés d'indolopyrone et leur procédé de préparation
BRPI0816255A2 (pt) Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
WO2008076954A3 (fr) Composés hétérocycliques et procédés d'utilisation de ceux-ci
WO2008061720A3 (fr) Utilisation de diterpènes tricycliques et leurs dérivés pour le traitement, le cotraitement ou la prévention de troubles inflammatoires et/ou troubles des articulations
EP1937633B8 (fr) Derives d'acide biphenyloxyacetique utilises pour le traitement de maladies respiratoires
WO2009071690A3 (fr) Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine
WO2007048801A3 (fr) Medicaments augmentant le desir sexuel comprenant des derives de benzimidazolone
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
WO2008119097A8 (fr) Agent pharmaceutique contre les démangeaisons et la douleur
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2007098964A3 (fr) Composés ciblant les récepteurs sigma
WO2008116663A3 (fr) Dérivés de tétrahydro-naphtalène-amine substitués par un hétérocyclyle, leur préparation et utilisation en tant que médicaments
WO2009099553A3 (fr) Utilisation d’inhibiteur de kinase pour le traitement de l’athérosclérose
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2010121675A3 (fr) Thiazolyl-benzimidazoles
WO2009003719A3 (fr) Dérivés d'indane-amine, leur préparation et leur utilisation comme médicaments
WO2008152068A3 (fr) Dérivés de [1,10]-phénanthroline pour le traitement de maladies neurodégénératives ou hématologiques
WO2007009721A3 (fr) Derives de pyrazoline substitues indoline, preparation et utilisation comme medicaments
WO2008043788A3 (fr) Nouveaux composés
GT200600109A (es) Derivados de acido pirimidincarboxilico y su uso
WO2007098967A3 (fr) Composés ciblant les récepteurs sigma

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07823877

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007823877

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE